Healthcare Services

Herceptin Market Analysis: Growth Potential and Future Trends

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Herceptin Market Between 2026 And 2030?

The herceptin market size has demonstrated robust growth in recent years. It is projected to expand from $7.48 billion in 2025 to $7.92 billion in 2026, at a compound annual growth rate (CAGR) of 5.8%. The historical expansion of this market can be attributed to factors such as the increased diagnosis of HER2-positive cancer, the widespread clinical acceptance of trastuzumab, growth in oncology infusion infrastructure, the availability of biologic manufacturing capabilities, and the inclusion of herceptin in standard treatment guidelines.

The herceptin market is projected to experience robust expansion over the coming years. This market is anticipated to reach $9.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.8%. The upward trend during the forecast period is driven by factors such as intensified biosimilar competition, a surge in demand for cost-effective biologic treatments, the expansion of targeted oncology drug pipelines, the growing embrace of individualized cancer therapies, and increased funding for biologic drug innovation. Key developments expected during this timeframe involve a rise in the uptake of biosimilar trastuzumab products, more widespread utilization of subcutaneous formulations, an expansion of combination therapy protocols, an increasing emphasis on affordable biologic treatment options, and improved oversight of treatment results.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/herceptin-global-market-report

Which Factors Are Influencing The Growth Of The Herceptin Market?

The growing occurrence of breast cancer is anticipated to fuel the expansion of the herceptin market in the future. Breast cancer, a malignancy developing in breast cells, typically originates in milk ducts or lobules, encompassing forms like invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and HER2-positive breast cancer. This surge in breast cancer cases is partially attributed to shifts in lifestyle, including greater alcohol intake, unhealthy eating habits, and insufficient exercise, all elevating the risk. Consequently, with more individuals receiving a breast cancer diagnosis, especially those with HER2-positive types, the need for potent targeted treatments like herceptin steadily increases. An illustrative example is seen in January 2025, where the American Cancer Society, a US-based cancer organization, anticipates around 319,750 new breast cancer cases in 2025, alongside an estimated 42,680 fatalities due to the illness. Therefore, the escalating prevalence of breast cancer is indeed propelling the growth of the herceptin market.

Which Segment Types Are Examined In The Herceptin Market Segment Study?

The herceptin market covered in this report is segmented –

1) By Product: Biologic, Biosimilar

2) By Application: Breast Cancer, Gastric Cancer

3) By Payer: Commercial And Private, Public

4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy

Subsegments:

1) By Biologic: Intravenous (IV) Biologics, Subcutaneous (SC) Biologic

2) By Biosimilar: Intravenous (IV) Biosimilars, Subcutaneous (SC) Biosimilars

Which Trends Are Influencing Demand In The Herceptin Market?

Leading companies within the herceptin market are actively developing novel therapeutic solutions, including innovative biosimilar products, with the goal of improving patient access and enhancing treatment outcomes for HER2-positive cancers. These advanced biosimilar products are highly similar versions of approved biologic drugs, developed through sophisticated biotechnology to ensure equivalent safety, efficacy, and quality. For example, in April 2024, Accord BioPharma Inc., a US-based pharmaceutical company, secured approval from the U.S. Food and Drug Administration for HERCESSI (trastuzumab-strf), which is a biosimilar to herceptin (trastuzumab), designated for the management of HER2-overexpressing breast and gastric cancers. Such biosimilars as HERCESSI demonstrate comparable efficacy and safety to their reference biologics, while also potentially providing more cost-effective treatment alternatives.

Which Players Are Part Of The Competitive Landscape Of The Herceptin Market?

Major companies operating in the herceptin market are Roche Holding AG, Pfizer Inc., Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Biocon Limited, Dr. Reddy’s Laboratories, Celltrion Inc., Samsung Biologics, Fresenius Kabi, Intas Pharmaceuticals Ltd, Zydus Lifesciences Ltd, AryoGen Pharmed, Shanghai Henlius Biotech Inc., Prestige Biopharma Pte Ltd, Alvotech, Coherus BioSciences, BioXpress Therapeutics, Amneal Pharmaceuticals, Novartis AG

Get The Full Herceptin Market Report:

https://www.thebusinessresearchcompany.com/report/herceptin-global-market-report

Which Region Is The Top Contributor To The Herceptin Market By Share?

North America was the largest region in the herceptin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herceptin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Herceptin Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/herceptin-global-market-report

Browse Through More Reports Similar to the Global Herceptin Market 2026, By The Business Research Company

Genital Herpes Market Report 2026

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Oleoresin Market Report 2026

https://www.thebusinessresearchcompany.com/report/oleoresin-global-market-report

Epinephrine Market Report 2026

https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795